Telangiectasias Therapeutics Pipeline Analysis 2018

CITY, Country, 2019-Jul-26 — /EPR Network/ —

Telangiectasias are dilated blood vessels located near the surface of skin or mucous membranes. These often appear as fine pink or red lines, which temporarily whiten under pressure. Although this disease can be developed in healthy individuals, telangiectasias is known to be a prime feature of systemic and limited scleroderma and dermatomyositis.

Download the sample report at:

Telangiectasias may occur in rosacea, in certain systemic diseases (such as ataxia-telangiectasia, scleroderma), or in long-term therapy with topical fluorinated corticosteroids.

Get the sample report at:

Spider telangiectases, costal fringe, generalised essential telangiectasia, hereditary haemorrhagic telangiectasia, angioma serpiginosum, unilateral naevoid telangiectasia and poikilodermatous mycoses fungoides are some types of primary telangiectases. Although most telangiectases are self-limiting, for cosmetically sensitive areas of the body, gentle cautery can be used for small numbers of lesions.

Make enquiry before purchase at:

  • The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
  • Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.


About Us:

Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455


Connect with us on: LinkedIn | Twitter | Facebook

Matched content

Editor’s pick

Do NOT follow this link or you will be banned from the site!